<DOC>
	<DOCNO>NCT02987868</DOCNO>
	<brief_summary>In recent randomize , double-blind , cross-over clinical trial , serum growth hormone ( hGH ) increase 682 % baseline 120 minute oral administration amino acid-based dietary supplement ( SeroVital ) , p=0.01 v placebo . In contrast mechanism hGH stimulation ghrelin , hypothesize supplement suppresses somatostatin , know inhibitor hGH TSH . To test hypothesis , measure triiodothyronine ( T3 ) administration amino acid-base supplement .</brief_summary>
	<brief_title>Effects Amino Acid-Based hGH Secretagogue Triiodythyronine</brief_title>
	<detailed_description>Two molecular target regulate synthesis secretion human growth hormone ( hGH ) include 1 ) ghrelin , endogenous ligand secrete stomach also appetite-stimulation property distinct hGH-stimulating effect , 2 ) somatostatin , family 14 28 amino acid peptide act potent noncompetitive inhibitor release hGH . We recently report oral administration 2.9g/dose SeroVital , blend l-lysine HCl , l-arginine HCL , oxo-proline , N-acetyl-l-cysteine , l-glutamine , schizonepeta ( aerial part ) powder , lead significant 682 % mean increase endogenous hGH level male female subject period 120 minute follow acute consumption . In work present , seek characterize mechanistic target associate measured increase endogenous hGH SeroVital , hypothesize somatostatin . We test hypothesis assay thyroid function , secondary inhibition target somatostatin . We compare findings ghrelin-based hGH secretagogues .</detailed_description>
	<criteria>12 healthy male 4 healthy female Between 18 70 year Pregnant nursing Taking chronic medication include birth control pill .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Somatostatin</keyword>
	<keyword>Thyroid Hormone</keyword>
	<keyword>Growth Hormone</keyword>
</DOC>